OncoMyx Therapeutics rallies $50m Series B
OncoMyx Therapeutics, an immuno-oncology platform company, has raised $50 million in Series B financing.
8 December 2021•1 min read
OncoMyx Therapeutics, an immuno-oncology platform company, has raised $50 million in Series B financing.